Immuron Ltd. (NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin therapeutics for the treatment of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Equity Offerings

Immuron Prices Underwritten Public Offering of ADSsJuly 17, 2019 6:00 AM After-Hours Movers 07/16: (SGEN) (CTAS) (QCOM) Higher; (NUS) (IRMN) (SENS) (more...)July 16, 2019 6:02 PM Immuron (IMRN) Plans Public Offering of ADSsJuly 16, 2019 4:32 PM